ArticleOrphanet journal of rare diseases2026
Novel GJC2 and OBSCN variants co-segregating in a Chinese primary lymphedema pedigree.
Article in Orphanet journal of rare diseases, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundPrimary lymphedema (PL) is a genetically heterogeneous disorder of the lymphatic system. Despite the identification of numerous monogenic causes, the genetic etiology of many familial cases remains elusive, often exhibiting marked phenotypic variability that suggests non-Mendelian or complex inheritance patterns.
resultsWe investigated a four-generation Chinese pedigree presenting with autosomal dominant generalized lymphedema affecting all four limbs, with marked phenotypic variability. Whole-exome sequencing in eight key family members, followed by Sanger sequencing in all 26 available relatives, identified two novel heterozygous missense variants that co-segregated with the disease: GJC2 c.287G > T (p.Gly96Val) and OBSCN c.22393T > A (p.Phe7465Ile). The GJC2 variant affects the second transmembrane domain of connexin 47, whereas the OBSCN variant lies in immunoglobulin-like domain 55 of obscurin, a large cytoskeletal signaling protein not previously implicated in lymphedema. In silico structural modeling predicted that both variants alter local packing and compromise protein stability. Haplotype analysis revealed that these two genes, located approximately 210 kb apart on chromosome 1q42.13, reside on a shared haplotype block with linkage disequilibrium, consistent with co-inheritance as a single pathogenic haplotype.
conclusionsTo our knowledge, this is the first report linking OBSCN to human lymphedema. We propose a synergistic oligogenic model in which GJC2 disruption impairs lymphatic pumping coordination, while the co-segregating OBSCN variant compromises cytoskeletal integrity and RhoA signaling in lymphatic endothelial cells; together these effects could explain the early-onset, severe phenotype observed in this family. These findings expand the genetic spectrum of PL and highlight the importance of considering closely linked modifier genes in complex inheritance patterns.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.